The National Academies of Sciences, Engineering and Medicine (NASEM) announced late yesterday that a public comment session will be held next week relating to the committee charge of reviewing relevant literature regarding adverse events associated with COVID-19 vaccines and shoulder injury related to vaccine administration (SIRVA). The meeting will be live-streamed, and there is an opportunity for public comment.
The review of epidemiological, clinical, and biological evidence has been requested by the U.S. Department of Health and Human Services (DHHS) and appears to be in preparation for the addition of vaccine injuries to the federal vaccine injury table. According to the NASEM presentation given to the Advisory Commission for Childhood Vaccines (ACCV) in December 2022, the report and its findings are expected in March 2024.
Injuries Under Review
DHHS has asked the NASEM committee to review the medical literature for the following vaccine adverse events to determine if the evidence indicates that COVID-19 vaccines are causally associated:
- Guillain-Barrè Syndrome (GBS)
- chronic inflammatory demyelinating
- polyneuropathy (CIDP)
- transverse myelitis (TM)
- Bell’s palsy
- hearing loss
- chronic headaches
- infertility
- sudden death
- myocarditis/pericarditis
- thrombosis with thrombocytopenia syndrome (TTS)
- immune thrombocytopenic purpura (ITP)
- thromboembolic events (e.g., cerebrovascular accident (CVA), myocardial infarction (MI), pulmonary embolism, deep vein thrombosis (DVT)
- capillary leak syndrome
The review of literature for SIRVA will be the second review by the NASEM, with the first review published in their last report in 2012.